Ganot Ilan
SEC Form 4 insider trading activity
Ganot Ilan has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Ganot Ilan is listed as Director at Solid Biosciences Inc. Inside the rolling window, Ganot Ilan reported no open-market purchases and 5 open-market sales totaling $82K in SLDB. The largest disclosed transaction in the window is a sale of 7,205 SLDB shares on Feb 4, 2026, worth $46K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$82K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ganot Ilan made?
Ganot Ilan has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Ganot Ilan trade?
Ganot Ilan has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Ganot Ilan's most recent SEC Form 4 filing?
Ganot Ilan's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Ganot Ilan's total buy and sell value in the current window?
Inside the rolling retention window, Ganot Ilan bought $0 and sold $82K based on SEC Form 4 filings.
What was Ganot Ilan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,205 SLDB shares on 2026-02-04, worth $46K, per SEC Form 4 filings.